DIGENOMICS - Trademark Details
Status: 734 - Fifth Extension - Granted
Serial Number
88093564
Word Mark
DIGENOMICS
Status
734 - Fifth Extension - Granted
Status Date
2021-11-17
Filing Date
2018-08-27
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2019-03-19
Attorney Name
Law Office Assigned Location Code
N20
Employee Name
MILLER, DAVID S
Statements
Goods and Services
Medical research services; biomedical research services; structural and functional analysis of genomes; scientific research in the field of genomics; providing online, non-downloadable software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; providing online, non-downloadable software used for the sequencing and analyses of genomic data; providing online, non-downloadable software used to integrate and create data models; providing online computer databases of genomic sequences for scientific research, namely, for tracking, matching, searching, testing, aggregating, researching, and evaluating health status, and diagnosing diseases and gene mutations; software as a service (SAAS) services featuring software for analyzing and visualizing genomic data, and evaluating health status and diagnosing diseases, disorders, and syndromes; software as a service (SAAS) services featuring software for data management, for electronic storage of data in the field of clinical trials and electronic health records; providing online, non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, biochemistry; providing online, non-downloadable software for use in clinical trial data management and electronic health records; information technology consulting services relating to the collection, review, analysis and reporting of clinical trial and drug development information and electronic health records; development of scientific research and technology for purposes of evaluating health status disease diagnosis; DNA analysis services for scientific research purposes; providing medical and scientific research information in the field of genomics and clinical trials; custom development of biochemical reagents and assays; services of a chemical laboratory; medical research laboratory services, in particular in the fields of diagnostics and development of tests for clinical diagnosis and the detection of medical conditions and disorders
Goods and Services
Medical research services; biomedical research services; structural and functional analysis of genomes; scientific research in the field of genomics; software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; software used for the sequencing and analyses of genomic data; software used to integrate and create data models; databases of genomic sequences for tracking, matching, searching, testing, aggregating, researching, and evaluating health status, and diagnosing diseases and gene mutations; software as a service (SAAS) services featuring software for analyzing and visualizing genomic data, and evaluating health status and diagnosing diseases, disorders, and syndromes; software as a service (SAAS) services featuring software for data management, for electronic storage of data in the field clinical trials and electronic health records; computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, biochemistry; software for use in clinical trial data management and electronic health records; information technology consulting services relating to the collection, review, analysis and reporting of clinical trial and drug development information and electronic health records; development of scientific research and technology for purposes of evaluating health status disease diagnosis; DNA analysis services for scientific research purposes; providing medical and scientific research information in the field of genomics and clinical trials; diagnostic reagents, bioassays, and assay components for clinical, medical and medical laboratory use; custom development of biochemical reagents and assays; services of a chemical laboratory; medical research laboratory services, in particular in the fields of diagnostics and development of tests for clinical diagnosis and the detection of medical conditions and disorders
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-01-26
Primary Code
042
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Christina M. Licursi
Address
Please log in with your Justia account to see this address.
Madrid International Filings
Entry Number
1
Reference Number
A0083738
Original Filing Date USPTO
2019-02-27
International Registration Number
1459683
International Registration Date
2019-02-27
International Status Code
480
International Renewal Date
2029-02-27
Madrid History Events | ||
Date | Code | Description |
2019-02-27 | NEWAP | NEW APPLICATION FOR IR RECEIVED |
2019-02-27 | ACERT | AUTOMATICALLY CERTIFIED |
2019-02-27 | APPST | IR CERTIFIED AND SENT TO IB |
2019-04-04 | CREAT | APPLICATION FOR IR REGISTERED BY IB |
Trademark Events
Event Date | Event Description |
2018-09-06 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2018-12-11 | ASSIGNED TO EXAMINER |
2018-12-11 | NON-FINAL ACTION WRITTEN |
2018-12-11 | NON-FINAL ACTION E-MAILED |
2018-12-11 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2019-01-25 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2019-01-25 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2019-01-26 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-01-29 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2019-02-14 | ASSIGNED TO LIE |
2019-02-14 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2019-02-27 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2019-03-19 | PUBLISHED FOR OPPOSITION |
2019-03-19 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2019-05-14 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2019-05-29 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
2019-06-06 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2019-05-29 | AMENDMENT AFTER NOA NOT ENTERED |
2019-11-12 | TEAS EXTENSION RECEIVED |
2019-11-12 | EXTENSION 1 FILED |
2019-11-12 | EXTENSION 1 GRANTED |
2019-11-14 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2020-05-12 | TEAS EXTENSION RECEIVED |
2020-05-12 | EXTENSION 2 FILED |
2020-05-12 | EXTENSION 2 GRANTED |
2020-05-14 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2020-11-13 | TEAS EXTENSION RECEIVED |
2020-11-13 | EXTENSION 3 FILED |
2020-11-13 | EXTENSION 3 GRANTED |
2020-11-17 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-05-11 | TEAS EXTENSION RECEIVED |
2021-05-11 | EXTENSION 4 FILED |
2021-05-11 | EXTENSION 4 GRANTED |
2021-05-13 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-11-15 | TEAS EXTENSION RECEIVED |
2021-11-15 | EXTENSION 5 FILED |
2021-11-17 | EXTENSION 5 GRANTED |
2021-11-18 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |